Why can't Big Pharma slay Antibiotic Resistance? episode artwork

EPISODE · Mar 25, 2026 · 39 MIN

Why can't Big Pharma slay Antibiotic Resistance?

from How Science Speaks to Power · host Roger Jacobs

Big Pharma makes billions from medicine you may take for life, but their profit from marketing a drug you may need once in your life is too low to justify the effort. Science is coming up with many new antibiotic candidates , and we really need them- because superbugs are resistant to the antibiotics we already have. Our current system of funding new drugs is not working for us.We talk to researchers and patients about the obstacles and new ways forward to cure sepsis and develop drugs of high social value.

Episode metadata supplied by the publisher feed · Published Mar 25, 2026

Embed this episode

NOW PLAYING

Why can't Big Pharma slay Antibiotic Resistance?

0:00 39:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of How Science Speaks to Power?

This episode is 39 minutes long.

When was this How Science Speaks to Power episode published?

This episode was published on March 25, 2026.

Can I download this How Science Speaks to Power episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!